000 | 01321 a2200361 4500 | ||
---|---|---|---|
005 | 20250517214953.0 | ||
264 | 0 | _c20191230 | |
008 | 201912s 0 0 eng d | ||
022 | _a1473-4877 | ||
024 | 7 |
_a10.1080/03007995.2018.1476334 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDeleu, Dirk | |
245 | 0 | 0 |
_aOral disease-modifying therapies for multiple sclerosis in the Middle Eastern and North African (MENA) region: an overview. _h[electronic resource] |
260 |
_bCurrent medical research and opinion _c02 2019 |
||
300 |
_a249-260 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Systematic Review | ||
650 | 0 | 4 | _aAfrica, Northern |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 | _aMiddle East |
650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy |
700 | 1 | _aMesraoua, Boulenouar | |
700 | 1 | _aCanibaƱo, Beatriz | |
700 | 1 | _aMelikyan, Gayane | |
700 | 1 | _aAl Hail, Hassan | |
700 | 1 | _aEl-Sheikh, Lubna | |
700 | 1 | _aAli, Musab | |
700 | 1 | _aAl Hussein, Hassan | |
700 | 1 | _aIbrahim, Faiza | |
700 | 1 | _aHanssens, Yolande | |
773 | 0 |
_tCurrent medical research and opinion _gvol. 35 _gno. 2 _gp. 249-260 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/03007995.2018.1476334 _zAvailable from publisher's website |
999 |
_c28394045 _d28394045 |